DARS1-AS1 and plasma cell myeloma: In addition, further studies have shown that RBM39 inhibited the ubiquitination and degradation of RBM39 protein through the interaction with DARS-AS1, indicating that RBM39 might mediate the biological function of DARS-AS1 on multiple myeloma under hypoxic conditions [44].